Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

A common criticism of the pharmaceutical industry is that it fails to achieve transparency [ 1 , 2 ]. To allay concerns, the industry needs to collaborate openly with stakeholders to make medicines widely available and affordable—this will mean companies need to address some of their practices [ 1 , 3 , 4 ]. We suggest that an important practice to address is the presentation of health economic models.